"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
PROSED®/DS is indicated for the relief of discomfort of the lower urinary tract caused by hypermotility resulting from inflammation or diagnostic procedures and in the treatment of cystitis, urethritis and trigonitis when caused by organisms which maintain or produce an acid urine and are susceptible to formaldehyde.
DOSAGE AND ADMINISTRATION
Adults: One tablet orally 4 times per day followed by liberal fluid intake.
Older children: Dosage must be individualized by physician. Not recommended for use in children up to 12 years of age.
Round, dark blue, sugar-coated tablets imprinted with "PROSED®/DS". Bottles of 100-NDC 15456-805-03 and Samples of 2-NDC 15456-805-02.
Store in a dry place between 15° and 30°C (59° to 86°F). Keep container tightly closed.
Medical Inquiries: 1-(888)-FERRING (1-(888)-337-7464) and www.prosed.com. Distributed by: FERRING PHARMACEUTICALS INC. PARSIPPANY, NJ 07054. Manufactured by: Contract Pharmacal Corp. Hauppauge, NY 11788. www.cpchealth.com. FDA Rev date: n/a
Last reviewed on RxList: 8/8/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Prosed DS Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.